Last updated: August 12, 2025
Introduction
China Patent CN105363035 (hereafter CN105363035) relates to a novel pharmaceutical invention. Understanding its scope and claims is crucial for stakeholders such as pharmaceutical companies, patent attorneys, and R&D strategists. This patent’s positioning within the Chinese patent landscape influences innovation pathways, licensing opportunities, and competitive strategies in the global or regional pharmaceutical markets.
Patent Overview and Technical Field
CN105363035 pertains to a family of compounds or methods involving a novel drug candidate or pharmaceutical formulation. The patent’s technical field likely resides within medicinal chemistry, pharmaceuticals, or biopharmaceuticals, focusing on therapeutic agents with enhanced efficacy, stability, or bioavailability.
Exact details on the invention's subject matter—such as specific chemical structures, formulations, or methods—are essential to interpreting scope but are not explicitly outlined here due to the summarized nature of this analysis. Nonetheless, patents in this category are characterized by claims that are either structurally narrow, targeting specific chemical entities, or broader, encompassing classes of compounds or methods.
Claims Analysis
1. Claim Types and Structural Hierarchy
Patent claims generally include independent and dependent claims:
- Independent claims define the broadest scope of the invention, establishing core features that distinguish the invention from prior art.
- Dependent claims add specific limitations or embodiments, refining the claims and adding scope clarification.
2. Scope of Claims
The scope of CN105363035 hinges on the breadth of the independent claims:
- If the independent claims specify a specific chemical compound, such as a particular derivative, the patent’s protection predominantly covers that molecule and structurally similar analogs with comparable functions.
- Conversely, if the claims adopt a Markush structure, encompassing a class of compounds, this extends the scope considerably, covering numerous derivatives within that chemical space.
3. Functional and Method Claims
Beyond compound claims, method claims related to synthesis, formulation, or specific therapeutic applications may be included. Such claims expand the patent’s coverage from compounds alone to processes or uses, influencing the patent’s strategic value.
4. Claim Limitations and Potential Gaps
- Narrow claims limit infringement risk but also restrict the patent's enforceability.
- Broader claims risk rejection during prosecution due to prior art or lack of novelty.
- The degree of claim encumbrance by limitations such as specific substituents, isosteres, or synthesis pathways influences overall protective scope.
Patent Landscape Context
1. Prior Art and Novelty
CN105363035’s patentability results from its novelty and inventive step vis-à-vis existing Chinese and international patent repositories, including:
- Related chemical entities disclosed in prior patents or literature.
- Existing therapeutic compounds with similar structures or mechanisms.
A comprehensive prior art search would reveal whether CN105363035 introduces a novel chemical scaffold, an improved formulation, or a new therapeutic use—each impacting the scope and strength of claims.
2. Similar Patents and Competitor Innovation
A landscape analysis likely identifies other Chinese patents targeting similar compounds or indications, such as:
- Patents focusing on molecular modifications to improve pharmacokinetics.
- Patents exploring specific disease treatments, like oncology, neurology, or infectious diseases.
The positioning of CN105363035 within this landscape depends on whether it offers incremental improvements or a groundbreaking composition/method.
3. Patent Families and Geographical Coverage
Assessing if CN105363035 extends into patent families abroad—for instance, via PCT applications or national phase entries—determines its potential global enforceability and licensing prospects.
Notably, the patent’s priority date and scope influence its resistance to challenges and freedom-to-operate analyses.
Legal and Strategic Implications
1. Patent Validity and Enforcement
- The scope of the claims directly impacts potential patent litigation. Narrow claims can be circumvented, whereas broad claims may face validity challenges.
- The scope focused on certain chemical structures might open avenues for design-arounds but also indicate strong positioning if well supported by data.
2. Infringement Risks and Opportunities
- Companies developing drugs within the claimed chemical space must assess infringement risks.
- Licensees, or those seeking to develop alternative compounds, might leverage narrower claims to steer clear of infringement.
3. R&D and Commercial Strategy
- The scope informs R&D direction—whether to innovate within the claim boundaries or challenge the patent.
- The patent landscape influences decisions on joint ventures, licensing, or research exclusions within Chinese markets.
Conclusion
CN105363035 embodies a strategic patent within China’s pharmaceutical patent framework, with its scope shaped by the specificity of claims and the breadth of inventive features. Its position in the patent landscape—relative to prior art and similar patents—determines its enforceability and economic value. Stakeholders should continuously monitor legal statuses, claim amendments, and related patents to safeguard or leverage this invention effectively.
Key Takeaways
- Scope Balancing: Narrow claims offer precision but limit protection; broader claims provide wider coverage but face higher scrutiny.
- Patent Landscape Vigilance: Regular landscape analysis reveals infringement risks and innovation opportunities pertinent to this patent’s comparative positioning.
- Strategic Licensing: Understanding the patent’s claims enables licensing negotiations, R&D focusing, and competitive advantage in China’s burgeoning pharmaceutical market.
- Legal Defensibility: Well-drafted claims aligned with innovative features stand stronger against validity challenges.
- Global Expansion: Considering international protections bolsters the patent’s value, especially for multi-market drug development.
FAQs
1. What is the significance of the claims' breadth in CN105363035?
The breadth of claims determines the scope of legal protection—a broader scope covers more potential infringing products but faces higher complexity during patent prosecution and validity assessments.
2. How does CN105363035 compare to related patents in China?
Its positioning depends on the novelty of its chemical structures or methods relative to existing patent documents; comparative landscape analysis reveals overlaps and gaps.
3. Can the patent claims be challenged or invalidated?
Yes; challenges may target novelty, inventive step, or added subject matter, especially if prior art closely resembles the claimed subject matter.
4. What strategic advantages does CN105363035 offer to a drug developer?
It potentially secures market exclusivity for specific compounds or methods, supporting proprietary formulations and preventing competitors from launching competing products.
5. How can companies navigate potential infringement risks related to CN105363035?
By thoroughly analyzing the scope of claims against their product pipelines and considering licensing or design-around strategies aligned with the patent’s specific claims, companies can mitigate infringement risks.
References
[1] Chinese Patent CN105363035 Public Document (Exact bibliographic details to be supplemented upon access).
